ArticleGland surgery2025
Transaxillary suspension endoscopic-assisted subcutaneous gland excision: clinical outcomes and significance in gynecomastia management.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gynecomastia (GM) is the most common male breast condition, often leading to psychological distress despite its benign nature. Surgical treatment is typically required for moderate to severe cases. Traditional subcutaneous mastectomy via midaxillary incision, while cosmetically concealed, may increase the risk of bleeding due to limited access. Endoscopic-assisted approaches offer better cosmetic and recovery outcomes but often require pneumoperitoneum, which carries physiological risks. To address these issues, a novel suspension endoscopic-assisted technique without pneumoperitoneum has been developed. This study aims to evaluate its safety, efficacy, and aesthetic outcomes compared to the conventional open approach. Methods: This single-center, non-randomized, retrospective comparative study analyzed 103 male patients with GM who underwent surgical treatment between January 2021 and March 2024. Patients were divided into two groups: 43 underwent lipolysis-free suspension endoscopic-assisted subcutaneous mastectomy (observation group), while 60 received conventional subcutaneous mastectomy via midaxillary incision (control group). Primary endpoints included perioperative parameters and complications. Secondary endpoints comprised a composite patient-reported satisfaction score assessed at the 180-day follow-up. Psychological parameters were evaluated using instruments at baseline and postoperatively to assess treatment-related psychological improvements. Results: Baseline demographic characteristics were comparable between the two groups (P>0.05). The observation group demonstrated significantly reduced intraoperative blood loss [32.00 (27.00-43.00) Conclusions: This retrospective study demonstrated that transaxillary suspension endoscopic-assisted subcutaneous mastectomy significantly reduced intraoperative blood loss, postoperative drainage volume, and drainage duration, albeit with a longer operative time. While the incidence of postoperative complications was comparable between groups, the endoscopic approach was associated with significantly higher patient-reported satisfaction across multiple aesthetic domains and yielded greater improvement in postoperative psychological adaptation, particularly in interpersonal sensitivity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.